Press release
Hepatitis B Virus (HBV) Market Forecast 2025-2034: Analysing Major Trends, Opportunities, and Growth Drivers
Hepatitis B Virus (HBV) Market Forecast
The hepatitis B virus (HBV) market will grow from $6.71 billion in 2024 to $7.37 billion in 2025, reflecting a CAGR of 9.9%. The growth is driven by the rising prevalence of HBV, growing demand for diagnostics, expanding vaccine coverage, and increasing awareness of the virus.
The Hepatitis B Virus (HBV) market is expected to reach $10.72 billion by 2029, growing at a CAGR of 9.8%, driven by personalized medicine, rising vaccination programs, and healthcare spending. Trends include new drug development and partnerships in biological therapies.
What Key Elements Are Boosting Growth in the Hepatitis B Virus (HBV) Market?
The high prevalence of hepatitis B infections is expected to propel the growth of the hepatitis B virus market. Hepatitis B is a liver infection caused by the hepatitis B virus (HBV), and while it is preventable through vaccination, rising infection rates are increasing the demand for diagnostic tests and treatment options. For instance, in April 2024, the World Health Organization (WHO) reported that in 2022, 254 million people worldwide were living with chronic hepatitis B, with 1.2 million new cases occurring annually. Therefore, the growing prevalence of hepatitis B infection is driving the hepatitis B virus market.
Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12867&type=smp
Who Are the Major Industry Players Fueling Hepatitis B Virus (HBV) Market Expansion?
Major companies operating in the hepatitis b virus (hbv) market are Pfizer Inc., Johnson & Johnson Services Inc., F. Hoffmon La Roche Ltd., Merck & Co. Inc., AbbVie Inc., Bayer AG, Bristol-Myers Squibb Company, AstraZeneca PLC, Sanofi SA, GlaxoSmithKline PLC, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Gilead Sciences Inc., Boehringer Ingelheim International GmbH, Mylan N.V., Teva Pharmaceutical Industries Ltd., Vertex Pharmaceuticals Incorporated, Eisai Co. Ltd., Aurobindo Pharma Limited, Apotex Corp., Lupin Pharmaceuticals Inc., Cadila Healthcare Ltd., Celltrion Inc., Dynavax Technologies Corporation, Accord Healthcare Inc., Par Pharmaceutical Inc., Arrowhead Pharmaceuticals Inc., Arbutus Biopharma Corporation, Globeimmune Inc., Antios Therapeutics Inc.
Which Key Developments Are Influencing the Hepatitis B Virus (HBV) Market?
In the hepatitis B virus (HBV) market, Abbott Laboratories launched the HBsAg Next Qualitative Solution Test in May 2022, which improves early HBV detection. This chemiluminescent microparticle immunoassay (CMIA) helps detect the virus in human blood, thus aiding early diagnosis and better patient outcomes.
How Is the Segmentation of the Hepatitis B Virus (HBV) Market Defined?
The hepatitis B virus (HBV) market covered in this report is segmented -
1) By Type: Acute, Chronic
2) By Treatment: Immune Modulator Drugs, Antiviral Drugs, Vaccine, Surgery
3) By Age Group: Pediatrics, Adults, Seniors
4) By End User: Medical Providers, Patients, Healthcare Payers
Subsegments:
1) By Acute HBV: Asymptomatic Acute HBV, Symptomatic Acute HBV, Severe Acute HBV
2) By Chronic HBV: Chronic Hepatitis B (HBeAg Positive), Chronic Hepatitis B (HBeAg Negative), Chronic Hepatitis B With Compensated Liver Disease, Chronic Hepatitis B With Decompensated Liver Disease, Chronic Hepatitis B With Hepatocellular Carcinoma (HCC)
Pre-Book Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/hepatitis-b-virus-hbv-global-market-report
What Is the Leading Region in the Hepatitis B Virus (HBV) Market?
North America was the largest region in the hepatitis B Virus (HBV) market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in hepatitis B virus (HBV) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
What Is Covered In The Hepatitis B Virus (HBV) Global Market Report?
- Market Size Analysis: Analyze the Hepatitis B Virus (HBV) Market size by key regions, countries, product types, and applications.
- Market Segmentation Analysis: Identify various subsegments within the Hepatitis B Virus (HBV) Market for effective categorization.
- Key Player Focus: Focus on key players to define their market value, share, and competitive landscape.
- Growth Trends Analysis: Examine individual growth trends and prospects in the Market.
- Market Contribution: Evaluate contributions of different segments to the overall Hepatitis B Virus (HBV) Market growth.
- Growth Drivers: Detail key factors influencing market growth, including opportunities and drivers.
- Industry Challenges: Analyze challenges and risks affecting the Hepatitis B Virus (HBV) Market.
- Competitive Developments: Analyze competitive developments, such as expansions, agreements, and new product launches in the market.
Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12867
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Learn More About The Business Research Company
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Hepatitis B Virus (HBV) Market Forecast 2025-2034: Analysing Major Trends, Opportunities, and Growth Drivers here
News-ID: 3851387 • Views: …
More Releases from The Business research company
Segment Evaluation and Major Growth Areas in the Personalized Testing and Supple …
The personalized testing and supplements sector is gaining remarkable traction, driven by advancements in technology and a rising consumer focus on tailored health solutions. As more individuals seek customized wellness options, this market is set to experience substantial expansion in the coming years. Here's an in-depth look at its current valuation, key players, significant trends, and the main market segments shaping its future.
Market Valuation and Expansion Forecast for Personalized Testing…
Top Players and Market Competition in the Skin Microbiome Industry
The skin microbiome market is emerging as a significant area of interest due to growing awareness about the critical role of skin health and innovative skincare technologies. As research advances and consumer preferences shift towards more natural and science-backed products, this market is set to undergo substantial growth. Let's explore the current market size, key players, driving factors, and upcoming trends shaping the skin microbiome industry.
Projected Expansion in the Skin…
Key Strategic Developments and Emerging Changes Shaping the Upadacitinib Market …
The upadacitinib market is poised for significant expansion over the coming years, driven by advances in treatment options and increasing awareness of autoimmune diseases. This report delves into the market's current size, key drivers, major players, and the emerging trends shaping its future trajectory.
Steady Growth Expected in Upadacitinib Market Size Through 2029
The market for upadacitinib is projected to reach $2.54 billion by 2029, growing at a robust compound annual…
Analysis of Key Market Segments Driving the Alzheimer's Disease Diagnostic Marke …
The Alzheimer's disease diagnostic sector is rapidly evolving as advancements in technology and healthcare infrastructure open new possibilities for early detection and personalized treatment. With rising awareness and innovative approaches, this market is poised for significant growth in the coming years. Let's explore the current market size, key drivers, leading companies, and emerging trends that are shaping this critical healthcare field.
Projected Market Size and Growth Trends in Alzheimer's Disease Diagnostics…
More Releases for HBV
Emerging Hepatitis B Virus (HBV) Market Trends: Rising Emphasis On Highly Sensit …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts
Hepatitis B Virus (HBV) Market Size Growth Forecast: What to Expect by 2025?
The market for the hepatitis B virus (HBV) has expanded significantly in the last few years. The market is set to grow from its size of $6.71 billion in 2024 to an anticipated $7.37 billion in…
HIV/HBV/HCV Test Kits Market - Break the chain: Detect and prevent HIV, HBV, and …
Newark, New Castle, USA: The "HIV/HBV/HCV Test Kits Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors.
HIV/HBV/HCV Test Kits Market: https://www.growthplusreports.com/report/hivhbvhcv-test-kits-market/8774
This latest report researches the industry structure,…
Hepatitis B Virus [HBV] Treatment market ready to register a 5.30% CAGR
Actual Numbers & In-Depth Analysis, Business opportunities, Market Size Estimation Available in Full Report.
Executive Summary -:
A comprehensive research report created through extensive primary research (inputs from industry experts, companies, stakeholders) and secondary research, the report aims to present the analysis of Global Hepatitis B Treatment Market by Type (Therapeutics and Vaccines), By End-User (Male and Female) for the regions (North America, Europe, Asia—Pacific and ROW) and By Country (U.S., Canada,…
Global Hepatitis B Virus (HBV) Market: 10-Year Demand Forecast (2016-2025)
Hepatitis B is a virus that infects the liver. For most adults who suffer from it for a short time, it is called acute hepatitis B. Sometimes the virus causes a long-term infection which is called chronic hepatitis B. Over time, it can damage the liver. Babies and young children infected with the virus are more likely to get chronic hepatitis B. Abdominal pain, fever, dark urine and joint pain…
Rising Prevalence of HBV and HCV Drives the Global Hepatitis Diagnostics Market
Hepatitis is a medical condition characterized by inflammation of the liver which often leads to other complications such as jaundice, anorexia, liver failure and cirrhosis. Hepatitis is generally of two types- acute when it lasts for less than six months and chronic when it lasts for longer period. It can be caused by a group of viruses called as hepatitis viruses which include groups A, B, C, D, and E.…
Global Hepatitis B Virus (HBV) Market: 10-Year Demand Forecast (2016-2025)
Hepatitis B is a virus that infects the liver. For most adults who suffer from it for a short time, it is called acute hepatitis B. Sometimes the virus causes a long-term infection which is called chronic hepatitis B. Over time, it can damage the liver. Babies and young children infected with the virus are more likely to get chronic hepatitis B. Abdominal pain, fever, dark urine and joint pain…
